The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37
Open accessAbstract
Natural antimicrobial peptides (AMPs) provide prototypes for the design of unconventional antimicrobial agents. Existing bulk assays measure AMP activity but do not provide details of the growth-halting mechanism. We use fluorescence microscopy to directly observe the attack of the human antimicrobial peptide LL-37 on single Escherichia coli cells in real time. Our findings strongly suggest that disruption of the cytoplasmic membrane is not the growth-halting mechanism. At 8 μM, LL-37 binding saturates the outer membrane (OM) within 1 min. Translocation across the OM and access to the periplasmic space (5–25 min later) correlates in time with the halting of growth. Septating cells are attacked more readily than nonseptating cells. The halting of growth may occur because of LL-37 interference with cell wall biogenesis. Only well after growth halts does the peptide permeabilize the cytoplasmic membrane to GFP and the small dye Sytox Green. The assay enables dissection of antimicrobial design criteria into two parts: translocation across the OM and the subsequent halting of growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Determination of minimum inhibitory concentrations
Andrews, J. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.5 · Cited by 4,129
Culture Medium for Enterobacteria
Neidhardt, F. C., Bloch, P. L., & Smith, D. F. (1974) · Journal of Bacteriology · doi:10.1128/jb.119.3.736-747.1974 · Cited by 2,958
Hospital-Acquired Infections Due to Gram-Negative Bacteria
Peleg, A. Y., & Hooper, D. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0904124 · Cited by 1,495
Amphipathic, α-helical antimicrobial peptides
Tossi, A., Sandri, L., & Giangaspero, A. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<4::aid-bip30>3.0.co;2-m · Cited by 1,247
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
APD2: the updated antimicrobial peptide database and its application in peptide design.
Wang, G., Li, X., & Wang, Z. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn823 · Cited by 941
Membrane Pores Induced by Magainin
Ludtke, S. J., He, K., Heller, W. T., Harroun, T. A., Yang, L., & Huang, H. W. (1996) · Biochemistry · doi:10.1021/bi9620621 · Cited by 802
Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils
Turner, J., Cho, Y., Dinh, N.-N., Waring, A. J., & Lehrer, R. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2206 · Cited by 798
Levine, M., Nalin, D., Hornick, R., Bergquist, E., Waterman, D., Young, C., Sotman, S., & Rowe, B. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90299-4 · Cited by 685
Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37
Johansson, J., Gudmundsson, G. H., Rottenberg, M. E., Berndt, K. D., & Agerberth, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3718 · Cited by 661
Giangaspero, A., Sandri, L., & Tossi, A. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2001.02494.x · Cited by 636
Oren, Z., Lerman, J. C., Gudmundsson, G. H., Agerberth, B., & Shai, Y. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3410501 · Cited by 599
Gudmundsson, G. H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B., & Salcedo, R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0325z.x · Cited by 578
Structure–activity studies on magainins and other host defense peptides
Maloy, W. L., & Kari, U. P. (1995) · Biopolymers · doi:10.1002/bip.360370206 · Cited by 490
Mimicry of Antimicrobial Host-Defense Peptides by Random Copolymers
Mowery, B. P., Lee, S. E., Kissounko, D. A., Epand, R. F., Epand, R. M., Weisblum, B., Stahl, S. S., & Gellman, S. H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja077288d · Cited by 443
TRANSPLANT OR CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKAEMIA
(1989) · The Lancet · doi:10.1016/s0140-6736(89)92393-3 · Cited by 377
Thomas, J. D., Daniel, R. A., Errington, J., & Robinson, C. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02253.x · Cited by 282
Cathelicidin LL-37: A Multitask Antimicrobial Peptide
Bucki, R., Leszczyńska, K., Namiot, A., & Sokołowski, W. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0057-2 · Cited by 235
Self-citationPorcelli, F., Verardi, R., Shi, L., Henzler-Wildman, K. A., Ramamoorthy, A., & Veglia, G. (2008) · Biochemistry · doi:10.1021/bi702036s · Cited by 189
Lipid Headgroup Discrimination by Antimicrobial Peptide LL-37: Insight into Mechanism of Action
Neville, F., Cahuzac, M., Konovalov, O., Ishitsuka, Y., Lee, K. Y. C., Kuzmenko, I., Kale, G. M., & Gidalevitz, D. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.067595 · Cited by 174
Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum
Bucki, R., Byfield, F. J., & Janmey, P. A. (2007) · European Respiratory Journal · doi:10.1183/09031936.00080806 · Cited by 110
Self-citationCytoplasmic Protein Mobility in Osmotically Stressed Escherichia coli
Konopka, M., Sochacki, K. A., Bratton, B. P., Shkel, I. A., Record, M. T., & Weisshaar, J. C. (2008) · Journal of Bacteriology · doi:10.1128/jb.00536-08 · Cited by 107
Self-citationProtein Diffusion in the Periplasm of E. coli under Osmotic Stress
Sochacki, K. A., Shkel, I. A., Record, M. T., & Weisshaar, J. C. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2010.11.044 · Cited by 105
Self-citationEpand, R. F., Wang, G., Berno, B., & Epand, R. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00321-09 · Cited by 94
Primate cathelicidin orthologues display different structures and membrane interactions
Morgera, F., Vaccari, L., Antcheva, N., Scaini, D., Pacor, S., & Tossi, A. (2008) · Biochemical Journal · doi:10.1042/bj20081726 · Cited by 48
Gable, J. E., Schlamadinger, D. E., Cogen, A. L., Gallo, R. L., & Kim, J. E. (2009) · Biochemistry · doi:10.1021/bi900996q · Cited by 24
Cited by
Antimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
The value of antimicrobial peptides in the age of resistance
Magana, M., Pushpanathan, M., Santos, A. L., Leanse, L., Fernandez, M., Ioannidis, A., Giulianotti, M. A., Apidianakis, Y., Bradfute, S., Ferguson, A. L., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30327-3 · Cited by 1,150
A comprehensive summary of LL-37, the factotum human cathelicidin peptide
Vandamme, D., Landuyt, B., Luyten, W., & Schoofs, L. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.11.009 · Cited by 567
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms
de Breij, A., Riool, M., Cordfunke, R. A., Malanovic, N., de Boer, L., Koning, R. I., Ravensbergen, E., Franken, M., van der Heijde, T., Boekema, B. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4044 · Cited by 555
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
Metadata
- Authors
- Sochacki, K. A., Barns, K. J., Bucki, R., & Weisshaar, J. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2011-04-04
- Volume
- 108
- Issue
- 16
- Pages
- E77-81
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2046796256
- Cited by
- 267
- References
- 27
- FWCI
- 11.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.